ALIDS(@ALInfectDis) 's Twitter Profile Photo

Limitations in susceptibility testing - one of several factors that highlights the importance of antibiotic asm.org/index.php/mbio…

account_circle
Hillary Stires, PhD(@HillStirSci) 's Twitter Profile Photo

Nothing like a peer reviewed paper led by a fierce group of patient advocates highlighting the need for improved dosing in oncology to start your Sunday. 👏🏼👏🏼👏🏼

account_circle
Certara(@Certara) 's Twitter Profile Photo

This report by AgencyIQ on the FDA's dose optimization guidance for oncology products provides insights into the contrasting viewpoints of regulators, researchers, patients, and industry.

Read the full article here: ow.ly/HZZu50OzHHW

This report by AgencyIQ on the FDA's dose optimization guidance for oncology products provides insights into the contrasting viewpoints of regulators, researchers, patients, and industry.  

Read the full article here:  ow.ly/HZZu50OzHHW 

#FDAguidance #DoseOptimization
account_circle
Matt Brown(@mlbrownrx) 's Twitter Profile Photo

Interesting that 40%+ in the CREDIBLE study received reduced doses of cefiderocol due to renal impairment. When mortality was attributed to baseline GN pathogen, ~2/3 received reduced doses. Opportunity for ?

account_circle
Melissa Johnson(@IDPharmacist) 's Twitter Profile Photo

On the issue of cefiderocol for cUTI there were 14 “yes” votes and 2 “no” votes from the advisory committee. Some calls for additional data, and labeling warnings about increased mortality seen in the CREDIBLE study. FDA Drug Information SIDP

On the issue of cefiderocol for cUTI there were 14 “yes” votes and 2 “no” votes from the advisory committee. Some calls for additional data, and labeling warnings about increased mortality seen in the CREDIBLE study. @FDA_Drug_Info @SIDPharm #IDtwitter
account_circle
Blaze(@blaze_ai) 's Twitter Profile Photo

Grow your Twitter with Blaze.

Our tool offers deep insights into your followers' demographics, behavior, and influence, allowing you to optimize your strategies for maximum impact. Try Blaze for free now and see the difference it can make.

withblaze.app/?utm_source=tw…

account_circle
InsightRX(@InsightRX) 's Twitter Profile Photo

The granted accelerated approval for the first drug approved to treat HER2-mutant non-small cell lung cancer, following a blinded, randomized study designed using guidelines: bit.ly/3QYnJi5

The #FDA granted accelerated approval for the first drug approved to treat HER2-mutant non-small cell lung cancer, following a blinded, randomized #DoseOptimization study designed using #ProjectOptimus guidelines: bit.ly/3QYnJi5 #Oncology #DrugDevelopment
account_circle
Troy Lester(@warptroy) 's Twitter Profile Photo

Modern middle-mile logistics strategies are critical to your business.

You need to optimize the entire journey if you want the lowest costs and the happiest customers.

account_circle
Hillary Stires, PhD(@HillStirSci) 's Twitter Profile Photo

Physicians lower doses to deal with side effects and sometimes even start lower than the approval. Another great set of work supporting a need for better dose optimization (complements the.right.dose’s findings!) - IMO should be BEFORE approval.

account_circle
Maryam Lustberg MD MPH(@maryam_lustberg) 's Twitter Profile Photo

Yes and increasing knowledge among the oncology community to be more aware of these data and paradigm shifts in dosing of targeted therapies. The Right Dose was a movement started by patients to do this.

account_circle
Janice Cowden(@JaniceTNBCmets) 's Twitter Profile Photo

Thanks to AnneL, founder the.right.dose, & all members, plus our brilliant Medical Advisory Board, for moving the needle forward on imp of of targeted tx for pts w/ . Out w/ MTD paradigm, in w/ personalized Med approach.
🎯🧵👇🏻

account_circle
Janice Cowden(@JaniceTNBCmets) 's Twitter Profile Photo

For some people living with HER2+ breast cancer, this is encouraging news! Treatment-related toxicities can significantly impair QoL, & de-escalation offers potential imp through patient-centered medicine approach.



account_circle
Paolo Tarantino(@PTarantinoMD) 's Twitter Profile Photo

De-Escalation Has Lasting Benefits for HER2+ Breast Cancers medscape.com/viewarticle/99… - thanks to @medscape for featuring our long-term analysis of the APT trial Sara Tolaney Dana-Farber’s Breast Oncology Center

account_circle
michał klasowski 中(@klasaaa) 's Twitter Profile Photo

Being exposed to low-dose ionizing radiation is associated with an increase in pediatric patients' risk of developing cancer, according to a new study published in JAMA Network Open.
bit.ly/35hFdhe

account_circle
West Physics(@west_physics) 's Twitter Profile Photo

Looking for ALARA best practice ideas and decreasing dose in your patients and staff? West Physics' own Richard R. Miguel will be a panelist on the Imaging Technology News (ITN) Editorial Roundtable Series! Registration at lnkd.in/ginSHaNP

Looking for ALARA best practice ideas and decreasing dose in your patients and staff? West Physics' own Richard R. Miguel will be a panelist on the Imaging Technology News (ITN) Editorial Roundtable Series! Registration at lnkd.in/ginSHaNP
#medicalphysics #doseoptimization
account_circle
Liz Garrett-Mayer, PhD(@LGM_Biostats) 's Twitter Profile Photo

About half oncologists who responded to ASCO's survey agreed that patients should start at a lower than the approved dose, and increase if well-tolerated. ascopubs.org/doi/10.1200/OP…

About half oncologists who responded to @ASCO's survey agreed that patients should start at a lower than the approved dose, and increase if well-tolerated. #doseoptimization #startlowgoslow ascopubs.org/doi/10.1200/OP…
account_circle
West Physics(@west_physics) 's Twitter Profile Photo

West Physics' own Richard R. Miguel, M.S., DABR will be one of 3 industry experts discussing the management of fluoroscopy radiation dose. Register for free at workcast.com/register?cpak=…

physics

West Physics' own Richard R. Miguel, M.S., DABR will be one of 3 industry experts discussing the management of fluoroscopy radiation dose. Register for free at workcast.com/register?cpak=… 

#medicalphysics #experts #learn #healthcare #medical #doseoptimization #fluoroscopy
account_circle
metaMartha(@Martha__Carlson) 's Twitter Profile Photo

📢New paper from the.right.dose=Important. An overwhelming majority of the responding oncologists - 97% - would be willing to discuss individualized dosing with patients based upon the patient's unique attributes link.springer.com/epdf/10.1007/s…

account_circle
IQVIA Asia Pacific(@IQVIA_AsiaPac) 's Twitter Profile Photo

We have recently collaborated with regional experts, Prof Jayesh Desai, Prof Do-Youn Oh and Prof Pan Hongming, for an in-depth discussion on FDA's . Watch the interview as we delve into development & : bit.ly/43qIY2F

We have recently collaborated with regional experts, Prof Jayesh Desai, Prof Do-Youn Oh and Prof Pan Hongming, for an in-depth discussion on FDA's #ProjectOptimus. Watch the interview as we delve into #earlyphase #oncology development & #doseoptimization: bit.ly/43qIY2F
account_circle